Fetal presentation of congenital dyserythropoietic anemia type 1 with novel compound heterozygous CDAN1 mutations

Blood Cells Mol Dis. 2018 Jul:71:63-66. doi: 10.1016/j.bcmd.2018.03.002. Epub 2018 Mar 20.

Abstract

The congenital dyserythropoietic anemias are a heterogeneous group of disorders characterized by anemia and ineffective erythropoiesis. Congenital dyserythropoietic anemia type I (CDA1) can present in utero with hydrops fetalis, but more often it presents in childhood or adulthood with moderate macrocytic anemia, jaundice, and progressive iron-overload. CDA1 is inherited in an autosomal recessive manner, with biallelic pathogenic variants in CDAN1 or C15orf41. This case report documents a severe fetal presentation of CDA1 where we identified two novel compound heterozygous mutations in CDAN1 and describes the associated pathologic findings and levels of iron-regulatory proteins hepcidin, erythroferrone, and GDF15.

Keywords: CDAN1 mutations; Congenital dyserythropoietic anemia; Erythroferrone; GDF15; Hepcidin.

Publication types

  • Case Reports
  • Research Support, N.I.H., Extramural

MeSH terms

  • Adult
  • Anemia, Dyserythropoietic, Congenital / blood
  • Anemia, Dyserythropoietic, Congenital / diagnosis*
  • Anemia, Dyserythropoietic, Congenital / genetics*
  • Biomarkers
  • Biopsy
  • Bone Marrow
  • Female
  • Genetic Association Studies*
  • Genetic Predisposition to Disease*
  • Glycoproteins / genetics*
  • Heterozygote*
  • Humans
  • Infant, Newborn
  • Male
  • Mutation*
  • Nuclear Proteins

Substances

  • Biomarkers
  • CDAN1 protein, human
  • Glycoproteins
  • Nuclear Proteins